SAVIENT PHARMACEUTICALS INC 4/A
4/A · SAVIENT PHARMACEUTICALS INC · Filed Dec 19, 2007
Insider Transaction Report
Form 4/AAmended
Lamm Robert
SVP, Quality & Reg. Affairs
Transactions
- Exercise/Conversion
Common Stock, $.01 par value per share
2007-12-14$4.67/sh+812$3,792→ 47,418 total - Sale
Common Stock, $.01 par value per share
2007-12-14$18.49/sh−5,000$92,427→ 42,418 total - Sale
Common Stock, $.01 par value per share
2007-12-13$17.84/sh−5,000$89,200→ 46,606 total - Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2007-12-13$4.67/sh−5,000$23,350→ 10,812 totalExercise: $4.67From: 2003-06-10Exp: 2012-06-10→ Common Stock, $.01 par value per share (5,000 underlying) - Exercise/Conversion
Common Stock, $.01 par value per share
2007-12-13$4.67/sh+5,000$23,350→ 51,606 total - Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2007-12-14$4.67/sh−812$3,792→ 10,000 totalExercise: $4.67From: 2003-06-10Exp: 2012-06-10→ Common Stock, $.01 par value per share (812 underlying)
Footnotes (2)
- [F1]This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 105b-1 under the Securities Exchange Act of 1934.
- [F2]Original timely filed Form 4 showed 5,000 shares exercised and acquired on 12/14/2007 - correct number was 812 shares exercised and acquired.